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the evolution and phylodynamics 
of serotype A and SAT2 foot-and-
mouth disease viruses in endemic 
regions of Africa
s. Lycett  1, V. N. tanya4, M. Hall2, D. p. King3, s. Mazeri1, V. Mioulet3, N. J. Knowles3, 
J. Wadsworth3, K. Bachanek-Bankowska3, Victor Ngu Ngwa5, K. L. Morgan6 & 
B. M. de C. Bronsvoort1
Foot-and-mouth disease (FMD) is a major livestock disease with direct clinical impacts as well as 
indirect trade implications. Control through vaccination and stamping-out has successfully reduced 
or eradicated the disease from Europe and large parts of South America. However, sub-Saharan Africa 
remains endemically affected with 5/7 serotypes currently known to be circulating across the continent. 
This has significant implications both locally for livestock production and poverty reduction but also 
globally as it represents a major reservoir of viruses, which could spark new epidemics in disease free 
countries or vaccination zones. This paper describes the phylodynamics of serotypes A and SAT2 in 
Africa including recent isolates from Cameroon in Central Africa. We estimated the most recent common 
ancestor for serotype A was an East African virus from the 1930s (median 1937; HPD 1922–1950) 
compared to SAT2 which has a much older common ancestor from the early 1700s (median 1709; HPD 
1502–1814). Detailed analysis of the different clades shows clearly that different clades are evolving and 
diffusing across the landscape at different rates with both serotypes having a particularly recent clade 
that is evolving and spreading more rapidly than other clades within their serotype. However, the lack 
of detailed sequence data available for Africa seriously limits our understanding of FMD epidemiology 
across the continent. A comprehensive view of the evolutionary history and dynamics of FMD viruses 
is essential to understand many basic epidemiological aspects of FMD in Africa such as the scale of 
persistence and the role of wildlife and thus the opportunities and scale at which vaccination and other 
controls could be applied. Finally we ask endemic countries to join the OIE/FAO supported regional 
networks and take advantage of new cheap technologies being rolled out to collect isolates and submit 
them to the World Reference Laboratory.
Foot-and-mouth disease (FMD) is a one of the most important livestock diseases globally. It is a highly contagious 
viral disease affecting all cloven hoofed animals, causing direct production losses in adult animals and mortality 
in young animals, as well as economic losses through trade interruption1,2. It is caused by the foot-and-mouth dis-
ease virus (FMDV), a positive-sense single-stranded RNA virus in the genus Aphthovirus, family Picornaviridae. 
Though generally considered a single disease because of the common clinical signs3, from an epidemiological 
and control point of view, it is better considered as at least 7 immunologically distinct diseases4 based on the 7 
recognised serotypes currently circulating globally5. These are serotypes O and A found around the world, the 
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Southern African Territories (SAT) 1, 2 and 3 serotypes found predominantly in sub-Saharan Africa, serotype C 
(which has not been reported since 20046) and Asia1 (found in Asia).
FMD has historically been thought of as important only in middle or high income economies with highly 
improved breeds and intensive production systems. Introductions into these systems can have devastating effects 
such as in the UK 2001 outbreak7. FMD is often not considered a priority in endemic regions where low produc-
tion and extensive livestock systems predominate8. However, there is growing evidence to support the alternative 
argument that at the individual household level FMD is important in terms of direct losses of production9, lower 
fertility and loss of other livestock services such as draft power10. Furthermore, it has indirect impacts preventing 
access to international markets, limiting genetic improvement and preventing development of diary produc-
tion8,10,2. Also, there is a global societal good to control of FMD in endemic areas, as these reservoirs of disease 
present a clear and present risk to disease free areas or areas using vaccination, through trade in animal products 
and animal movements as demonstrated by the recent rapid expansion of the serotype O/ME-SA/IND-2001 line-
age across the Middle East and North Africa Southeast and East Asia from Indian sub-continent11,12.
Sub-Saharan Africa (SSA) is an enormous geographical area with a huge diversity of cultures, cattle rearing 
practices and wildlife, including the Cape buffalo (an important reservoir of SAT serotypes), which influence 
the epidemiology of FMD in different regions13. Currently 5 of the 7 serotypes of FMD virus (O, A, SAT1, SAT2 
and SAT3) are reported to be circulating in SSA5,14,13, and West and Central Africa have had at least 4 of these 
serotypes (O, A, SAT1 and SAT2) in recent years15–18. However, because much of SSA has endemic FMD there 
are relatively few submissions to the World Reference Laboratory (WRLFMD), at The Pirbright Institute, from 
Africa. This lack of basic surveillance data on FMD viruses has major implications for control both locally, region-
ally and internationally.
FMD control has been very successful in many parts of the world, such as Europe and South America and 
is making significant impacts now in S.E. Asia19. These have largely been based around vaccination campaigns 
at 4–6 month intervals and movement controls. In addition, recent support from the Food and Agricultural 
Organization (FAO) through the European Commission for the Control of FMD (EuFMD) together with the 
World Organization for Animal Health (OIE) has led to the development of the progressive control pathway (PcP) 
for FMD19 that helps countries frame their control efforts and provides realistic step-wise targets for national gov-
ernments to help focus efforts. A key element in this pathway is the development of robust surveillance systems 
to allow regular collection of FMD viruses for typing and sequencing as well as vaccination. However, the details 
of what individual countries in Africa are doing in regards to surveillance and vaccination and the number of 
outbreaks they experience is not generally available. Endemic areas in SSA experience regular clinical outbreaks 
although the serotypes may be different with each epidemic wave4,20. Through better surveillance information, 
understanding of livestock movements21 and contact with wildlife and international cooperation and coordina-
tion it may be possible to isolate and control individual serotypes in certain zones or to use natural geographical 
barriers to help zone off areas for control. The emerging view is that FMD control produces a significant amount 
of public good, justifying the need for national and international public investment in control2.
The FMD virus genome encodes for a single polyprotein that is post-translationally processed into 4 capsid 
proteins (VP1–4) and 10 non-structural proteins, bounded by 5 and 3 untranslated regions22. The evolutionary 
changes observed in phylogenetic studies of FMD viruses reflect both genetic drift of strains through repeat selec-
tion via transmission bottle necks as small sub-populations of viruses spread from animal to animal23–25, as well as 
possible recombination events in the non-structural coding regions26,27. Molecular epidemiology and evolution of 
FMDV has traditionally been studied using the sequences coding for VP1 (627–657 nt, depending on serotype), 
the most variable capsid structural protein containing relevant antigenic domains. This region reliably classifies 
the viruses into serotypes, topotypes and strains for most practical epidemiological applications13.
In 2012 we conducted a follow-up study to our 2000 study15,4, of circulating FMD viruses in the Adamawa 
and the Northwest Regions of Cameroon, to investigate the genetic changes in the serotypes and strains over the 
intervening 12 years and understand their relationship to the relatively small number of other sequences submit-
ted from Africa over this period particularly in relation to the North African outbreaks28. This is important as 
FMD surveillance in SSA is still fragmented and at very low coverage. This paper describes the latest patterns of 
serotypes A and SAT2 in SSA, as these were the dominant strains circulating in Cameroon at the time, estimates 
the dates of most recent common ancestors for key lineages and topotypes, and discusses the different rates of 
spread of key lineages and topotypes.
Results
Circulation patterns in serotype A. A set of 875 serotype A VP1 sequences was compiled from GenBank, 
the WRLFMD and Cameroon studies, and used to create a maximum likelihood phylogenetic tree (Fig. 1) show-
ing the relationship between strains on different continents. The data set consists of African (19%), Asian (63%), 
European (3%) and South American (15%) sequences, and shows three global clades of predominantly Asian 
(purple), South American and European (blues) and African (red) taxa. There are three African sequences within 
the South American and European clade (from Morocco and Libya 1977–1983), and seven African sequences 
within the Asian clade (from Libya in 2009 and Egypt 2010–2013), showing that there are occasional incursions 
of non-African lineages into Northern Africa, however the majority of the circulation in Africa is from African 
strains, and no sequence from elsewhere clusters with the main African clade.
Next, to look at the transmission pattern of serotype A within Africa, we used sequences from Africa clus-
tering within the main African clade (154 in total - also see Fig. S1) to perform a time resolved phylogeographic 
analysis using BEAST. Region labels were added to the sequences (Central, Eastern, Northern and Western; there 
were no Southern), and the number of transmissions between regions were inferred using an asymmetric discrete 
traits model on the time resolved trees. Figure 2 shows the time resolved tree of the African serotype A sequences, 
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with the branches and nodes coloured by inferred discrete region trait and the size of the ancestral nodes reflect-
ing the probability of the inferred region at that point.
The tree in Fig. 2 indicates that all these serotype A sequences have an Eastern Africa most recent common 
ancestor in the 1930’s (median 1937 with 95% HPD: 1922–1950), and suggests that there is an interchange of 
viruses between Northern, Central and Western Africa (genotypes A-IV, V and VI), and between Eastern only, or 
Eastern and Northern Africa separately (genotypes A-I and A-VII). From the tree, it can also be seen that there 
is only one case of Central to Eastern transmission (within A-IV) related to a sample from Eritrea in 1998 (A/
ERI/3/98), highlighting that although Eastern-Central transmission is possible, it does not seem to occur very 
frequently.
Figure 1. Maximum likelihood phylogenetic tree of worldwide FMD serotype A viruses based on 875 VP1 
sequences.
Figure 2. Time scaled tree of 154 serotype A VP1 sequences from Africa.
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The lower clade in Fig. 2 contains all the Central and Western serotype A strains, and some Northern strains. 
It is split into two main sub-clades; genotype A-VI contains strains isolated in the 1970s from Cameroon, 
Nigeria, and Ghana, and also recent viruses isolated from Benin in 2010, whereas A-IV contains strains isolated 
from Sudan from 1977–1984 and again in 2006, and the majority of the Cameroonian strains from 2000 and 
2012–2013.
Figure 3 (and Fig. S2) shows the spatial distribution of the sampling locations, together with the approximate 
spatial extent of the genotypes. From these it can be seen that A-I, II, III and A-VII are in Eastern Africa, and 
overlap with A-IV in the Northern region only.
Overall, the pattern suggests that the serotype A viruses are potentially circulating in at least 2 quite separate 
pools in Central-Western Africa and Eastern Africa, and that Cameroon and Central Africa more widely may be 
an important bridging zone between virus pools (Fig. 3). However as with all these analyses in Africa, note the 
actual virus sampling coverage is extremely low so phylogenetic analyses might give a distorted view of the true 
transmission pattern.
Serotype SAT2 Diversity. A set of all available good quality SAT2 VP1 sequences was compiled from 
GenBank, the WRLFMD and Cameroon studies, of these only 9 were from outside Africa. These were in Saudi 
Arabia, Bahrain, Yemmen and Palistine (Gaza Strip), showing that the SAT2 serotypes are indeed mostly 
restricted to Africa with only occasional incursions into the Middle East. Using a set of 334 SAT2 VP1 sequences 
(see also Fig. S3) from Africa only (and removing very similar sequences, see Methods and Figs S4 and S5), 
Fig. 4 shows a maximum likelihood phylogenetic tree with the 14 SAT2 topotypes (clades) indicated13, and Fig. 5 
(and Fig. S6) shows the approximate spatial distribution of these topotype clades from the sampling locations. 
Similar to the overall pattern observed for serotype A, the SAT2 strains also show distinct topotype clades in 
Eastern-Southern Africa and Central-Western Africa, and the SAT2 strains from Cameroon fall into topotype 
VII, which is very widely geographically spread.
The time resolved maximum clade credibility tree for all 334 SAT2 sequences (Fig. S5) additionally indicates 
that the topotype clades are diverse; in contrast to the serotype A tree, the SAT2 tree shows a much longer time 
to most recent common ancestor (TMRCA for SAT2 is 1709 with 95% HPD:1502–1814), implying that the SAT2 
serotype has been circulating in Africa for at least a few centuries. Topotype VII appears to have a common 
ancestor from the 1950s (1954: 95% HPD:1906–1984) in East Africa and the more recent isolates in Cameroon 
from 2012/13 all appear to have a common ancestor with those from 2000 but not apparently directly descended 
from them.
Genetic Diversity. The average pairwise distance between all 154 African serotype A amino acids sequences 
is 13% (28 amino acids - also see Figs S7 and S9), and the average pairwise distance between the 72 sequences in 
A-IV, V and VI is 8% (20 amino acids). The genetic diversity between SAT2 topotype clades as estimated from 
amino acid sequences is quite large; and the average pairwise distances between sequences from one topotype 
to another is 18% (41 amino acids from alignment length of 224), whereas the average pairwise distance within 
a topotype is 7% (17 amino acids - also see Figs S8 and S9). It is likely that the differences between SAT2 topo-
types represent distinct antigenic variants29, and in comparison the average amino acid difference between H3N2 
human seasonal influenza vaccine updates is 12 (range 6–20) amino acids in HA1 (length 344, and the most 
variable part of the HA surface protein, equivalent to the partial VP1 sequences here).
Figure 3. Distribution of A VP1 sequences with approximate spatial extent of the topotypes.
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Diversity and Spatial Diffusion. Figure 6 (and Fig. S10) summarise measures of diversity (TMRCA and 
number of amino acid differences), estimates of the molecular clock evolutionary rate and spatial diffusion rate 
for topotypes I, IV, VII of SAT2, and A-I, A-VII and A-IV of serotype A using independent BEAST analyses. 
These clades were screened for recombination, but no recombination was found. The clades contain between 35 
(A-VII) and 69 (SAT2-IV) sequences collected over a time span of almost 60 years, however SAT2-I and SAT2-IV 
have long TMRCAs of 1900 (95% HPD:1830–1943) and 1752 (95% HPD: 1626–1846) respectively, whilst 
SAT2-VII and A-IV have much more recent TMRCAs of 1977 (95% HPD: 1944–1995) and 1975 (95% HPD: 
1973–1978) respectively. The corresponding differences in evolutionary rates are also pronounced - SAT2-VII 
and A-IV (means of 7e-3 and 9e-3 substitutions/site/year) have much higher rates than SAT2-I and SAT2-IV 
(means of 3e-3 and 7e-4 respectively). Similarly the spatial diffusion rate estimates of SAT2-VII, A-VII and A-IV 
Figure 4. Maximum Likelihood tree of African SAT2 viruses based on 334 VP1 sequences showing topotypes 
as designated by the FMD World Reference Laboratory.
Figure 5. Distribution of SAT2 VP1 sequences with approximate spatial extent of the topotypes.
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are much faster (means of 327, 110 and 209) than SAT2-I, SAT2-IV and A-I (means of 20, 9, and 34). Overall 
these results point to clades containing central, western and northern African strains, particularly SAT2-VII and 
A-IV having a faster and wider spatial spread, and faster evolutionary rate than the large eastern and southern 
SAT2-I, SAT2-IV and A-I clades.
sites under positive selection. To investigate the selection pressures on the A and SAT2 sequences, meas-
ures of non-synonymous to synonymous changes per site were calculated for each clade. Table 1 (and Fig. S11) 
summarises the number of sites under positive (diversifying) selection in the two antigenic regions and the sites 
Figure 6. Comparison of SAT2 and A sequences (whole datasets) and individual clades showing overall clock 
rate, root age, average number of amino acid differences within each clade and rate of spatial diffusion.
Clade #Pos.
Antigenic 
Region 0.1
Antigenic 
Region 0.2 Other #Neg. RGD Neg.
SAT2-I 1 — — 176 152 144,145,146
SAT2-IV 3 149 — 130,217 96 145,146
SAT2-VII 1 161 — — 84 144,146
A-I 1 — 197 — 83 146
A-VII 1 — 198 — 27 —
A-IV 2 — 196 43 69 145,146
Table 1. Sites under selection by clade. Sites are counted as positive (or negative) if any one of the following 
tests is significant SLAC ≤ 0.01, FEL ≤ 0.01, MEME ≤ 0.01, FUBAR ≥ 0.99 (equivalent to p-value ≤ 0.05 with 
Bonferroni correction).
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under positive and negative (purifying) selection in the receptor binding site RGD, and Table 2 summarises the 
sites under directional selection.
In all clades there were many sites under negative selection as expected, and the RGD site is conserved and 
under negative selection in the SAT2 serotypes. However, in serotype A not all positions of the RGD site are con-
served or are detected as under negative selection, particularly in clade A-VII. None of the clades have positively 
selected RGD sites. In clades SAT2-IV, SAT2-VII, and in the A clades, there are a few sites under positive selection 
and these tend to occur in the two surface exposed antigenic regions identified by Reeve et al.30,29. Additionally, 
several sites identified as under directional selection also occur in these antigenic regions. Interestingly, A-IV has 
more sites under directional selection than the other clades, including sites near the RGD sites. The sites under 
directional selection in the antigenic regions suggest that particular antigenic variants might be becoming more 
widespread over time (especially for A-IV).
Discussion
FMD remains a major global problem both for developed economies, where it has largely been eradicated but 
remain under threat of reintroductions and in low and middle income economies where it is under varying levels 
of control but still impacts production and causes trade blocks. SSA remains as a major reservoir of at least 5 
serotypes of FMD viruses and until controls are improved in these areas it will remain a threat to global livestock 
production. This analysis using phylogeographical approaches highlights a number of key issues in FMDV epide-
miology in SSA. It suggests that serotype A may have only been introduced relatively recently, and that East Africa 
may have been the origin, in the late 1930s, for the North, Central and West African isolates studied. In contrast 
the SAT2 serotype appears to have much older origins going back hundreds of years (and may have originated in 
Africa thousands of years ago in wildlife). Interestingly, the phylogenetic tree is also dominated by East African 
viruses and suggests that the appearance of SAT2 in Central Africa may be linked to East Africa and a common 
ancestor from the 1970s. The isolates from 2005 and later in Central and West Africa and the outbreaks in North 
Africa all appear to have a common ancestor in the 1970s or 1980s.
It is impossible to fully understand the degree of virus exchange between different regions as these areas are 
considered endemic for FMD and have not been routinely submitting isolates or reporting outbreaks. However, it 
is clear that from time to time there are transmission events between regions. However, again the lack of available 
isolates makes interpretation of these data difficult and there is a real risk of over interpretation. Furthermore, it is 
also not possible to say if vaccination is driving evolution of viruses in the region due to lack of data on outbreaks, 
vaccination coverage and vaccine use.
This analysis also highlights that although there is cross over between regions there appear to be antigenically 
distinct viruses circulating in different parts of Africa and therefore there needs to be more work done to identify 
strains that will provide protection in these different regions. Additionally, it seems that the clades SAT2-VII and 
A-IV containing Central, Western and Northern strains are not only distinct from their Eastern and Southern 
counter parts, but appear to be undergoing faster evolution and faster spatial spread. There are signatures of pos-
itive and directional selection in antigenic regions close to the receptor binding site of the VP1 protein in these 
clades, which are consistent with the faster evolutionary rates, and consequently provide an intriguing hypothesis 
to be tested in the future: that the increased spread of these clades could be due to a genetic change in the virus. 
An alternative hypothesis is that the increased spread of these clades is due to increased cattle movements (or 
human movements of animal products) particularly between the Central and Northern African regions.
This analysis has also highlighted our lack of data and understanding of the epidemiology of FMD viruses in 
SSA and points to the need for a major scaling up of surveillance and sampling across SSA to start to understand 
key questions on the flow and circulation of FMD viruses in SSA, the scale of persistence of strains and the role 
of wildlife. Without much higher coverage, whole genome sequences and spatial resolution of phylogenetic data 
it will be difficult to design strategies for FMD control across the continent. However, the development of simple 
to use tools such as the lateral flow device31 which could be extended to include African serotype specific bands32 
would give local veterinary services the means to type viruses in the field. This would be a major step forward 
for local veterinary staff and livestock keepers to understand the complexity of the epidemiology of FMD due to 
the number of different serotypes and start the education process needed to drive controls from the bottom up. 
Furthermore, these devices can be safely and cheaply submitted to reference laboratories where the virus can be 
eluted and sequenced33. Additionally mobile field sequencing technology is also now available as has been used in 
the Ebola outbreak in West Africa34. This also has the potential to increase the number of sequences, particularly 
Clade #Dir Antigenic Region 1 Antigenic Region 2 Other
SAT2-I 2 142(CE) — 86(CE)
SAT2-IV 2 — 201(SS), 202(SS) —
SAT2-VII 2 — 202(SS) 56(SS)
A-I 0 — — —
A-VII 1 149(CE) — —
A-IV 7 139(SS), 142(SS), 149(CE), 156(FD) —
45(SS), 68(SS), 
171(SS)
Table 2. Sites under directional selection by clade. Type of selection is indicated CE: Convergent evolution, SS: 
Selective Sweeps, FD: Frequency Dependeny selection.
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whole genomes and thus help improve local understanding as well as international understanding of the phyloge-
ography of FMD viruses, recombination events and vaccine driven selection in SSA.
Methods
Most of the sequences used in this study were taken from existing databases but a small set of new isolates from 
Cameroon were collected for this study. Details of field sample collection and processing are given in the sup-
plementary material. This field work was carried out with the Cameroonian Ministère de l’Élevage des Pêches et 
Industries Animales (MINEPIA) staff, following local guidelines and regulations, as part of their disease surveil-
lance activities and had approval from the Cameroonian Academy of Science.
GenBank Data. Global data sets of the VP1 region from serotypes A and SAT2 were downloaded from 
GenBank; an initial search for VP1 (or 1D) regions gave >900 and >400 sequences respectively. Of these we 
included good quality sequences in the final set with at least 240 nucleotides and both date and country infor-
mation, together with the new sequences from Cameroon, resulting in data sets of 875A and 394 SAT2 VP1 
sequences (95% and 75% of which had at least 600 nucleotides respectively).
African sequences were extracted from the global data sets and used for more detailed analysis. For the sero-
type A sequences, the 10 sequences from Northern Africa (6 Egypt, 2 Libya, 2 Morocco) which clustered with 
non-African sequences were excluded, as was Kenya/1965 (the outgroup). For the SAT2 sequences, the 9 of 
non-African origin were excluded (all from the Middle East). 9 serotype A and 9 SAT2 sequences from previ-
ously unreported isolates are also included in the data sets. These were collected in 2012 from the Adamawa and 
North West Regions of Cameroon and the sample codes and accession numbers of the sequenced samples are 
given in Table 3. A further 3 sequences from the Extreme North Region of Cameroon were provided by Ludi et 
al.35. Sequences from the same location, isolated within one week of each other and with less than 3 nucleotides 
difference were considered the same and the duplicates were removed from the final data set, leaving 154 serotype 
A sequences in the main monophyletic African clade, and 334 serotype SAT2 sequences.
phylogenetic analysis. Alignment. Initial nucleotide alignment was performed using ClustalW in 
BioEdit, the sequences were manually adjusted to the coding frame, and then aligned using MUSCLE in MEGA6 
on translated sequences.
Maximum Likelihood Trees. Maximum Likelihood trees on the global data sets were generated using RAxML 
with the general time reversible (GTR) model and gamma distributed site to site rate variation (4 categories) and 
100 bootsraps.
Phylodynamics and Phylogeography. Time scaled phylogenetic trees were inferring using BEAST 1.836. Initial 
model selection was performed by comparing the fit of substitution models, clock models and effective popula-
tion size tree prior models calculated using AICM with 100 bootstraps in Tracer 1.6, and Path sampling (PS) and 
Stepping Stone sampling (SS) in BEAST 1.837,38. Models were fitted on serotype A sequences using an MCMC 
chain with length 50,000,000 sampling every 5,000 and discarding the first 10% of samples as burn-in. The SRD06 
substitution model39 (which uses two HKY models with site to site rate variation, one model for positions 1 and 2, 
and another for position 3) was favoured above the GTR model with gamma distributed site to site rate variation 
(4 categories) with a Bayes Factor >100 (AICM, PS, SS), and the uncorrelated relaxed lognormal clock model 
Animal ID Serotype WRL ID Herd ID Division Clinical Case Accession
MBU21401 A A/CAR/58/2012 MBU214 Menchum Yes KX266277
MBU21403 A A/CAR/60/2012 MBU214 Menchum Yes KX266278
MBU21404 A A/CAR/61/2012 MBU214 Menchum Yes KX266279
MMC20703 A A/CAR/34/2012 MMC207 Momo No KX266275
MTA20901 A A/CAR/37/2012 MTA209 Mezam No NA
MTA20902 A A/CAR/38/2012 MTA209 Mezam No KX266276
MWU21501 A A/CAR/63/2012 MWU215 Menchum Yes KX266280
MWU21605 A A/CAR/72/2012 MWU216 Menchum Yes KX266282
MWU21603 A A/CAR/70/2012 MWU216 Menchum Yes KX266281
DNL20603 SAT2 SAT2/CAR/24/2012 DNL206 Djerem Yes KX266290
VNA20101 SAT2 SAT2/CAR/1/2012 VNA201 Vina Yes KX266283
VNA20102 SAT2 SAT2/CAR/2/2012 VNA201 Vina Yes KX266284
VNA20103 SAT2 SAT2/CAR/3/2012 VNA201 Vina Yes KX266285
VNA20104 SAT2 SAT2/CAR/4/2012 VNA201 Vina Yes KX266286
VNA20205 SAT2 SAT2/CAR/10/2012 VNA202 Vina Yes KX266289
VNA20203 SAT2 SAT2/CAR/8/2012 VNA202 Vina Yes KX266287
VNA20204 SAT2 SAT2/CAR/9/2012 VNA202 Vina Yes KX266288
VNG21801 SAT2 SAT2/CAR/78/2012 VNG218 Vina Yes KX266291
Table 3. Sample and herd codes for FMD isolates generated from 2012 sampling in Cameroon.
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was favoured over the strict clock with Bayes Factor >100 (AICM, PS, SS). The constant population size tree 
priors were favoured over flexible skygrid effective population size tree priors with Bayes Factor >6 for AICM40, 
but the reverse was true when using PS and SS (Bayes Factor >10). Therefore following Hall et al.41 we chose to 
use the flexible skygrid effective population size over time model for serotype A, although this made less than 1% 
difference to the TMRCAs for recent clades. Since the SAT2 sequences were very diverse and the TMRCA was 
much longer than for the serotype A sequences, we used a constant population size model when analysing all the 
topotypes together but a skygrid model when analysing individual topotypes.
A posterior set of 1000 trees for each of serotype A and SAT2 data sets was composed from a minimum of two 
independent runs, and the location states were reconstructed upon these trees in BEAST 1.8 using (i) asymmet-
ric discrete location trait models with Markov Jumps and (ii) continuous latitude and longitude homogeneous 
Brownian motion diffusion models42,43, (a random jitter of 0.01 was applied to the GPS sampling coordinates in 
order to give each isolate a unique location).
Selection tests. Sites under positive (diversifying) and negative (purifying) selection were detected within the 
SAT2-I, IV, VII and A-I, IV, VII clades using HyPhy on the DataMonkey server at https://www.datamonkey.org/ 
to estimate the non-synonymous to synomyous (dN/dS or dN-dS) ratios. SLAC (Single Ancestor Counting), 
FEL (Fixed Effects Likelihood), MEME (Mixed EffectsModel of Evolution) and FUBAR (Fast Unbiased Bayesian 
AppRoximation) methods were used (ref1) and a GTR (General Time Reversible, also known as “REV”) model 
was used as the basis for the codon models. On the HyPhy server, neighbour joining trees are automatically 
created from the uploaded sequences, and it is these which are used as the phylogeny within the codon-based 
selection tests. These selection tests have different detailed assumptions and performance depending on the size 
and variability of the data, but here a site was reported to be under positive or negative selection in the main text 
if it was significant under any of the tests with a p-value of 0.01 or FUBAR ≥0.99 posterior probability.
The SLAC44 method reconstructs the maximum likelihood ancestral sequences at each site in the alignment 
up the phylogenetic tree according to an overall fitted codon model (disallowing stop codons), and then counts 
the number of synonymous vs non-synonymous substitutions. This is the fastest and crudest method. FEL44 is 
also a site-by-site model, but here the rates of non-synonymous and synonymous substitution for each site are 
estimated independently as extra parameters besides the branch lengths and overall site variability. A likelihood 
ratio test is performed for each site to test whether a one parameter model (non-synonymous rate is the same as 
the synonymous rate) or a two parameter model (the rates are different) is applicable and hence the type of selec-
tion the site is under. In FUBAR45, independent non-synonymous and synonymous substitution rates are also 
inferred for each site (using Bayesian inference), and these are considered as random effects drawn from overall 
discretised distributions. MEME46 is another random effects model for individual sites, but rather than assuming 
that the selection pressure must be constant for a site over all time (and all branches), it allows the detection of 
both pervasive and episodic diversifying evolution along only some of the branches.
To further investigate the type of selection that individual sites were under, we also performed a Directional 
Evolution for Protein Sequences (DEPS) analysis47 on the HyPhy server; this analysis used only amino acid 
sequences and uploaded rooted neighbour joining trees, created from the nucleotide sequences and the oldest 
sequence per serotype as outgroup. The best fitting amino acid substitution model was determined from each 
clade separately and was JTT48 for serotype A A-I, IV, VII and SAT2-VII, and WAG49 for SAT2-I and IV. DEPS 
analyses considers the number and type of amino acid transitions per site and reports sites where the transitions 
indicate a: selective sweep site, consensus replacement site, repeated substitutions site (convergent evolution), rare 
residue substitution, or highly polymorphic site.
Recombination analyses. Since the presence of recombinant sequences can affect the phylogenetic results and 
results from selection tests, the VP1 sequences from the SAT2-I, IV, VII and A-I, IV, VII clades were screened for 
recombination using Single Break Point analysis with a GTR model on the HyPhy server, but no recombination 
was found.
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